Hunan Hansen Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 684.14 million compared to CNY 681.15 million a year ago. Revenue was CNY 684.14 million compared to CNY 681.15 million a year ago.

Net income was CNY 109.74 million compared to CNY 130.07 million a year ago. Basic earnings per share from continuing operations was CNY 0.2181 compared to CNY 0.2585 a year ago. Diluted earnings per share from continuing operations was CNY 0.2181 compared to CNY 0.2585 a year ago.